Aleva Neurotherapeutics Company

Aleva Neurotherapeutics is a company that develops implantable Deep Brain Stimulation systems using microfabricated devices based on MEMS technology. Their devices allow for Target Specific Stimulation and optimization of current therapies, and will enable the targeting of new areas of the brain and the measurement of neurophysiological activity. Their first application will be in Deep Brain Stimulation for Parkinson's Disease and Essential Tremor. The company has successfully completed an acute clinical trial for their first product, directSTIM, and is currently further developing it for long-term use. Aleva has been founded in 2008 in Lausanne, Switzerland, and has raised 42 MUSD to date from various investors. The company is ISO13485 certified.


Industry: NeuroTech
Investor Type: N/A
Headquarters: Lausanne, Vaud
Investment Stage: N/A
Funding Status: N/A
Employee Number: 1-10
Number Of Exists: N/A
Technology: Neuromodulation
Founded Date: 6/30/14